Jodi Euerle Eddy - 02 Aug 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP, Chief Info & Digital Off.
Signature: /s/ Vance R. Brown, Attorney-in-fact
Issuer symbol: BSX
Transactions as of: 02 Aug 2021
Net transactions value: -$73,168
Form type: 4
Filing time: 04 Aug 2021, 16:36:51 UTC
Previous filing: 27 Jul 2021
Next filing: 01 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Sale	$33,275	-727	-3.5%	$45.77	20,050	02 Aug 2021	Direct	F1
transaction	BSX	Common Stock	Options Exercise	$0	+1,973	+9.8%	$0.000000	22,023	03 Aug 2021	Direct	F2
transaction	BSX	Common Stock	Tax liability	$39,893	-876	-4%	$45.54	21,147	03 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-1,973	-25%	$0.000000	5,921	03 Aug 2021	Common Stock	1,973		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 3, 2021, the first anniversary of the date of grant.